CRH Medical Corp. (CRH.TO)

This has spent the last 18 months consolidating, and has just recently broke out of a trading range at around the $5.40-$5.50 level. He sees a lot of upside in this. A very well-run company. Their cash ROE is north of 30%, and their cash P/E ratio is at around 10 or 11.

He really likes the management team. He continues to hold it although the whole healthcare sector has been under scrutiny. Their earnings have grown as they made tuck-in acquisitions. They recently did some marketing. Over the next couple of years earnings estimates should go up.

They continue to execute. Did a big acquisition almost 2 years ago, and now are just doing smaller incremental acquisitions that continue to build out their business. He thinks the process will continue. This has bumped up a little in valuation, and as a result it dropped down in his ranking, so he recently sold his holdings. He wouldn’t be surprised if there was an equity issue from the company in the future.

A good, small-cap, Canadian health care stock. A teensy bit too expensive for him right now. He likes where the business is going. Would be a buyer at the bottom of the 52-week trading range. He likes management and the board. (See Top Picks.)

This is one of the stocks that gets bucketed into the healthcare rollup. Scores well on price momentum and on valuation. Has a good balance sheet and have been growing their earnings. However, they missed on their recent quarter. If looking to play some of these “growth by acquisition” stories, this would be the one to play.

They have a product that they have been marketing and selling for some time, and are taking the cash flow from that and putting it into acquiring anaesthesiology clinics in the US. Feels this is quite undervalued given their growth prospects. They are growing their bottom line by 30% a year. He likes this a lot.

He likes this whole space on a secular basis. You will have a wide disparity across the whole spectrum of stocks. We found a breakout at the beginning of August. There is support from the end of June. It made a move when it was supposed to. This stock has a nice trend. It has been in a nice band since the beginning of last year. There is some heavy duty volatility also.

(A Top Pick Sept 28/15. Up 23.28%.) Not sure who is buying this, but somebody is buying quite a bit of stock. Most healthcare stocks in Canada have not done well, but this one has. He really likes management, which underpromises and overdelivers. Recently made a few acquisitions which should be accretive. Only trading at about 8.5X EBITDA with very good growth over the next couple of years.

It has news out today. They have a consistent growth business and an acquisition business. They are making nice earnings growth. They buy a business for half what the stock trades for. They are slow and steady about it. They expanded into the US. Trading at a reasonable multiple. A year from now they will have done more acquisitions.

This has had a move at around the $4.50 level followed by a breakout. A pretty volatile stock. It looks like it wants to come back, so if you don’t own it, you will probably get your chance. If it gets about $5.10, it looks like it wants to have the $7 target. The whole space is a good place to be.

A little small for him, so he doesn’t own it. This is one of the healthcare rollup’s that has done it right. Valuation is pretty reasonable, especially one compared to some of their peers. They beat on their recent quarter, and are starting to generate cash flow. The balance sheet is in very good shape. They have managed to do acquisitions without debt, which is key for this type of business.

They are in the gastro anesthesiology business. They have found a couple of pretty good niches. They are market leaders in the markets they are operating in. They are now integrating the acquisitions. Impressive management team. It is a growth stock and not a value stock. He would like to meet them, however.

(Top Pick Jun 19/15, Down 9.00%) They have done a good job. They don’t need to raise prices. 9 times earnings. They are probably looking for acquisitions. The balance sheet looks good. A premier small cap name so he continues to hold it.

A good health care services firm. This would be a Hold to a Weak Buy at this time. Really likes what they have done longer-term. If you can get this at the bottom of the 52 week trading range, that would be his Buy point. He likes management and what they are doing long term.

From a seasonal perspective, you want to be looking more to the June timeframe. The chart shows a bit of resistance, and is now pulling back. There is a bit of head and shoulders topping pattern, which implies downside potential to almost $3.60. There is probably not much reason to get into this.